Anti-interferon-gamma monoclonal antibody

Drug Profile

Anti-interferon-gamma monoclonal antibody

Alternative Names: Anti-IFN-gamma monoclonal antibody; Anti-interferon-γ

Latest Information Update: 09 Apr 1999

Price : $50

At a glance

  • Originator Nonindustrial source; Toronto General Hospital
  • Class Monoclonal antibodies
  • Mechanism of Action Immunomodulators; Interferon gamma inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Diabetes mellitus; Transplant rejection

Most Recent Events

  • 09 Apr 1999 No-Development-Reported for Transplant rejection in Canada (Unknown route)
  • 09 Apr 1999 No-Development-Reported for Diabetes mellitus in Italy (Unknown route)
  • 13 Jan 1998 A preclinical study was added to the Pharmacodynamics section.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top